Weight Loss, the Obesity Paradox, and the Risk of Death in Rheumatoid Arthritis

scientific article published on July 2015

Weight Loss, the Obesity Paradox, and the Risk of Death in Rheumatoid Arthritis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ART.39136
P932PMC publication ID4826750
P698PubMed publication ID25940140

P50authorAndrew C. StokesQ56250308
P2093author name stringTed R Mikuls
Grant W Cannon
Kaleb Michaud
Liron Caplan
Joshua F Baker
Said Ibrahim
Vikas Majithia
Erica Billig
P2860cites workUnintentional weight loss in older adultsQ95354623
Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysisQ27348355
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisQ27860872
Weight loss from maximum body weight and mortality: the Third National Health and Nutrition Examination Survey Linked Mortality FileQ28275358
Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritisQ28390163
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative dataQ31011382
Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.Q33873068
Weight change, initial BMI, and mortality among middle- and older-aged adultsQ33993469
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registriesQ34216770
Accuracy of computerized outpatient diagnoses in a Veterans Affairs general medicine clinicQ34507931
Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old.Q34570264
Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional studyQ34613982
Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registryQ35025293
Global burden of cancer attributable to high body-mass index in 2012: a population-based studyQ35040247
Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritisQ35840753
Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors.Q36101689
Body-mass index and mortality among adults with incident type 2 diabetesQ37665897
Obesity paradox: conditioning on disease enhances biases in estimating the mortality risks of obesityQ37698568
Using maximum weight to redefine body mass index categories in studies of the mortality risks of obesityQ37701206
Obesity and the obesity paradox in heart failureQ38179548
Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgiaQ44148764
Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritisQ45012451
Effect of body mass index on mortality and clinical status in rheumatoid arthritisQ45158519
Prospective study of posttraumatic stress disorder and disease activity outcomes in US veterans with rheumatoid arthritisQ45330054
Unintentional weight loss is an independent predictor of mortality in a hemodialysis population.Q45908157
Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart StudyQ47176799
Body mass index, weight change, and death in older adults: the systolic hypertension in the elderly programQ47181921
Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study populationQ47346812
Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire formatQ48740361
Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish populationQ74466067
Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammationQ80932706
P433issue7
P921main subjectrheumatoid arthritisQ187255
obesityQ12174
P304page(s)1711-1717
P577publication date2015-07-01
P1433published inArthritis & RheumatologyQ4797636
P1476titleWeight Loss, the Obesity Paradox, and the Risk of Death in Rheumatoid Arthritis
P478volume67

Reverse relations

cites work (P2860)
Q47139877Aging, Obesity, and Inflammatory Age-Related Diseases
Q38637099Association Between Obesity and Migraine in Women
Q55563232Association of weight loss with improved disease activity in patients with rheumatoid arthritis: A retrospective analysis using electronic medical record data.
Q38763702Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations
Q38828456Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis.
Q91776881Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions
Q58545718Central role of RIPK1-VDAC1 pathway on cardiac impairment in a non-human primate model of rheumatoid arthritis
Q39993473Changes in Body Mass Related to the Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis
Q90483041Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patients
Q42332030High body mass index in rheumatoid arthritis: why we should promote physical activity
Q45940053Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis.
Q38829639Impact of Obesity on Remission and Disease Activity in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Q52312175Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications.
Q89998215Increased circulating adiponectin is an independent disease activity marker in patients with rheumatoid arthritis: A cross-sectional study using the KURAMA database
Q38895577Insight into rheumatological cause and effect through the use of Mendelian randomization
Q38687231Investigation Of Obesity-Related Mortality Rates In Delaware
Q27694518Managing cardiovascular risk in patients with inflammatory arthritis: practical considerations
Q38957697Methods Employed to Assess Weight Loss in Older Adults by Means of Electronic Medical Records: A Systematic Review
Q64229233Myopenia is associated with joint damage in rheumatoid arthritis: a cross-sectional study
Q37704275Obesity paradox and mortality in adults with and without incident type 2 diabetes: a matched population-level cohort study.
Q64125008Obesity, Weight Loss, and Progression of Disability in Rheumatoid Arthritis
Q47717791Prevalence of rheumatoid cachexia assessed by bioelectrical impedance vector analysis and its relation with physical function.
Q41120020Rheumatoid arthritis: Debunking the obesity-mortality paradox in RA.
Q87962122Rheumatoid arthritis: Disconnect in the effects of obesity on RA outcomes
Q50041537The Adiponectin Paradox in the Elderly: Associations with Body Composition, Physical Functioning, and Mortality.
Q28074864The Obesity Epidemic and Consequences for Rheumatoid Arthritis Care
Q89819053The outcomes of bariatric surgery on rheumatoid arthritis disease activity: a prospective cohort study
Q47175104Weight Change During the Early Rheumatoid Arthritis Period and Risk of Subsequent Mortality in Women With Rheumatoid Arthritis and Matched Comparators

Search more.